{"id":"W2589026218","doi":"10.1182/blood.v126.23.4893.4893","title":"Front-Line FLAG-IDA and Nove-HiDAC Chemotherapy Improves Overall Survival (OS) and Complete Remission Rates (CR) for Patients with Secondary or Therapy-Related AML Compared to 3&amp;7","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; CancerCare Manitoba; University of Toronto","funders":"","keywords":"Medicine; Flag (linear algebra); Cytarabine; Internal medicine; Etoposide; Idarubicin; Mitoxantrone; Salvage therapy; Fludarabine; Refractory (planetary science); Oncology; Surgery; Gemcitabine; Gastroenterology; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004999797,0.00007310076,0.0002416902,0.0005725073,0.0001484817,0.0003362816,0.0002112401,0.0001504232,0.001411714],"category_scores_gemma":[0.001046791,0.00007013104,0.0003630785,0.000648241,0.0001194623,0.0001619836,0.0001648045,0.0001666434,0.0001955065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000350319,"about_ca_system_score_gemma":0.0003869399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005643196,"about_ca_topic_score_gemma":0.001640474,"domain_scores_codex":[0.9996507,0.00009855208,0.0000804318,0.00006554006,0.0000755767,0.00002924833],"domain_scores_gemma":[0.9988201,0.0002724843,0.0007052663,0.00003618628,0.00008319991,0.00008265076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.004565635,0.0001693133,0.9022634,0.001168567,0.000416902,0.0006966095,0.00009621942,0.0001175605,0.005212061,0.00004290127,0.001346754,0.0839041],"study_design_scores_gemma":[0.0001806046,0.001775307,0.9864893,0.0002078304,0.0004407871,0.003566656,0.0001126024,0.0001914156,0.001675949,0.00001986428,0.005333764,0.000005860513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811844,0.01588013,0.000187005,0.00009835947,0.00001756122,0.00004823751,0.001224807,0.00001208277,0.001347589],"genre_scores_gemma":[0.9942556,0.004100903,0.0002281264,0.0001309478,0.00002380147,0.00002921796,0.0009988496,0.000002383592,0.0002301961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001411714,"threshold_uncertainty_score":0.004722655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04440066489194252,"score_gpt":0.3057987817389067,"score_spread":0.2613981168469642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}